• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素对胃肠道癌症发生发展的治疗作用。

Therapeutic actions of melatonin on gastrointestinal cancer development and progression.

作者信息

Glenister Rachael, McDaniel Kelly, Francis Heather, Venter Julie, Jensen Kendal, Dusio Giuseppina, Gaudio Eugenio, Glaser Shannon, Meng Fanyin, Alpini Gianfranco

出版信息

Transl Gastrointest Cancer. 2013 Jan 1;2(1):11-20. doi: 10.3978/j.issn.2224-4778.2012.08.03.

DOI:10.3978/j.issn.2224-4778.2012.08.03
PMID:24312749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3848957/
Abstract

Melatonin exerts a multitude of physiological functions including the regulation of the sleep cycle and circadian rhythm. Although the synthesis of melatonin in the pineal gland is regulated by changes in the light/dark cycle, the release of melatonin in the gastrointestinal tract is related to food consumption. Melatonin regulates antioxidative processes and it improves T-helper cell response by stimulating the production of specific cytokines. Melatonin is directly involved in preventing tumor initiation, promotion, and progression in a variety of cancers of the gastrointestinal tract including colorectal cancer, cholangiocarcinoma, hepatocarcinoma, and pancreatic carcinoma. This paper is a review of the literature regarding melatonin in the gastrointestinal tract and as a potential therapy for gastrointestinal cancers.

摘要

褪黑素发挥多种生理功能,包括调节睡眠周期和昼夜节律。虽然松果体中褪黑素的合成受光/暗周期变化的调节,但胃肠道中褪黑素的释放与食物摄入有关。褪黑素调节抗氧化过程,并通过刺激特定细胞因子的产生来改善辅助性T细胞反应。褪黑素直接参与预防包括结直肠癌、胆管癌、肝癌和胰腺癌在内的多种胃肠道癌症的起始、促进和进展。本文是一篇关于胃肠道中褪黑素以及作为胃肠道癌症潜在治疗方法的文献综述。

相似文献

1
Therapeutic actions of melatonin on gastrointestinal cancer development and progression.褪黑素对胃肠道癌症发生发展的治疗作用。
Transl Gastrointest Cancer. 2013 Jan 1;2(1):11-20. doi: 10.3978/j.issn.2224-4778.2012.08.03.
2
Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).褪黑素在完整及患病胃肠道中的定位与生物学活性
J Physiol Pharmacol. 2007 Sep;58(3):381-405.
3
Gut melatonin: A potent candidate in the diversified journey of melatonin research.肠道褪黑素:褪黑素研究多元化之旅中的有力候选者。
Gen Comp Endocrinol. 2021 Mar 1;303:113693. doi: 10.1016/j.ygcen.2020.113693. Epub 2020 Dec 10.
4
Physiological and pharmacological perspectives of melatonin.褪黑素的生理和药理学视角。
Arch Physiol Biochem. 2022 Oct;128(5):1346-1367. doi: 10.1080/13813455.2020.1770799. Epub 2020 Jun 10.
5
Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases.褪黑素在神经退行性和自身免疫性中枢神经系统疾病中的神经保护作用。
Encephalitis. 2023 Apr;3(2):44-53. doi: 10.47936/encephalitis.2022.00094. Epub 2023 Feb 8.
6
Gut clock: implication of circadian rhythms in the gastrointestinal tract.肠道时钟:昼夜节律对胃肠道的影响。
J Physiol Pharmacol. 2011 Apr;62(2):139-50.
7
Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.昼夜节律睡眠障碍:病理生理学及潜在的管理方法
CNS Drugs. 2001;15(4):311-28. doi: 10.2165/00023210-200115040-00005.
8
Therapeutic actions of melatonin in cancer: possible mechanisms.褪黑素在癌症中的治疗作用:可能的机制。
Integr Cancer Ther. 2008 Sep;7(3):189-203. doi: 10.1177/1534735408322846.
9
Role of circadian rhythm and endogenous melatonin in pathogenesis of acute gastric bleeding erosions induced by stress.昼夜节律和内源性褪黑素在应激诱导的急性胃出血性糜烂发病机制中的作用。
J Physiol Pharmacol. 2007 Dec;58 Suppl 6:53-64.
10
Melatonin: Nature's most versatile biological signal?褪黑素:自然界最具多功能性的生物信号?
FEBS J. 2006 Jul;273(13):2813-38. doi: 10.1111/j.1742-4658.2006.05322.x.

引用本文的文献

1
Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects.褪黑素的代谢性抗癌作用:临床相关前景
Cancers (Basel). 2021 Jun 16;13(12):3018. doi: 10.3390/cancers13123018.
2
Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.褪黑素可能会增加多效药物的抗癌潜力。
Int J Mol Sci. 2018 Dec 6;19(12):3910. doi: 10.3390/ijms19123910.
3
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.色氨酸代谢介导的肠道微生物群对肠道免疫的影响。
Front Cell Infect Microbiol. 2018 Feb 6;8:13. doi: 10.3389/fcimb.2018.00013. eCollection 2018.
4
Mechanisms of cholangiocyte responses to injury.胆管细胞对损伤反应的机制。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1262-1269. doi: 10.1016/j.bbadis.2017.06.017. Epub 2017 Jun 23.
5
Melatonin protects rats from radiotherapy-induced small intestine toxicity.褪黑素可保护大鼠免受放疗引起的小肠毒性。
PLoS One. 2017 Apr 12;12(4):e0174474. doi: 10.1371/journal.pone.0174474. eCollection 2017.
6
Novel insights into Notum and glypicans regulation in colorectal cancer.对Notum和磷脂酰肌醇蛋白聚糖在结直肠癌中的调控的新见解。
Oncotarget. 2015 Dec 1;6(38):41237-57. doi: 10.18632/oncotarget.5652.
7
Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model.褪黑素增强了普伐他汀在大鼠乳腺癌模型中的抗肿瘤作用。
Int J Exp Pathol. 2014 Dec;95(6):401-10. doi: 10.1111/iep.12094. Epub 2014 Sep 30.

本文引用的文献

1
Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality?饮食生活方式与结直肠癌的发病、复发及生存:是神话还是现实?
J Gastrointest Cancer. 2013 Mar;44(1):1-11. doi: 10.1007/s12029-012-9425-y.
2
Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.胰腺癌干细胞:肿瘤微环境中的调控网络与靶向治疗。
J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):614-20. doi: 10.1007/s00534-012-0547-1.
3
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?炎症性肠病相关结直肠癌:真实风险有多大?
World J Gastroenterol. 2012 Aug 7;18(29):3839-48. doi: 10.3748/wjg.v18.i29.3839.
4
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.肝细胞癌的防治:潜在靶点、实验模型与临床挑战。
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1129-59.
5
Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.膳食植物化学物在肝细胞癌的化学预防和治疗中的作用:体内证据、分子靶点和临床相关性。
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1191-232.
6
Non-coding RNAs as therapeutic targets in hepatocellular cancer.非编码 RNA 作为肝细胞癌的治疗靶点。
Curr Cancer Drug Targets. 2012 Nov 1;12(9):1073-80.
7
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma.慢性丙型肝炎患者发生肝细胞癌的特征。
Swiss Med Wkly. 2012 Aug 6;142:w13651. doi: 10.4414/smw.2012.13651. eCollection 2012.
8
Autophagy in pancreatic cancer pathogenesis and treatment.自噬在胰腺癌发病机制和治疗中的作用。
Am J Cancer Res. 2012;2(4):383-96. Epub 2012 Jun 28.
9
Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.pri-miRNA-371-372-373 多态性与乙型肝炎病毒感染患者肝细胞癌发生的相关性研究。
PLoS One. 2012;7(7):e41983. doi: 10.1371/journal.pone.0041983. Epub 2012 Jul 27.
10
Developments in liver transplantation for hepatocellular carcinoma.肝癌肝移植的进展。
Semin Oncol. 2012 Aug;39(4):510-21. doi: 10.1053/j.seminoncol.2012.05.008.